Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes assessment in multiple sclerosis.
Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Among authors: miller a. Ann Neurol. 1996 Sep;40(3):469-79. doi: 10.1002/ana.410400321. Ann Neurol. 1996. PMID: 8797541 Review.
Rapid disease course in African Americans with multiple sclerosis.
Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, Apatoff B, Coyle P, Goodman AD, Gottesman M, Granger C, Jubelt B, Krupp L, Lenihan M, Lublin F, Mihai C, Miller A, Munschauer FE 3rd, Perel AB, Teter BE, Weinstock-Guttman B, Zivadinov R, Herbert J. Kister I, et al. Among authors: miller a. Neurology. 2010 Jul 20;75(3):217-23. doi: 10.1212/WNL.0b013e3181e8e72a. Neurology. 2010. PMID: 20644149
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trial.
Freedman MS, Wolinsky JS, Wamil B, Confavreux C, Comi G, Kappos L, Olsson TP, Miller A, Benzerdjeb H, Li H, Simonson C, O'Connor PW; Teriflunomide Multiple Sclerosis Trial Group and the MRI Analysis Center. Freedman MS, et al. Among authors: miller a. Neurology. 2012 Jun 5;78(23):1877-85. doi: 10.1212/WNL.0b013e318258f7d4. Epub 2012 May 23. Neurology. 2012. PMID: 22622860 Clinical Trial.
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
Goodman AD, Rossman H, Bar-Or A, Miller A, Miller DH, Schmierer K, Lublin F, Khan O, Bormann NM, Yang M, Panzara MA, Sandrock AW; GLANCE Investigators. Goodman AD, et al. Among authors: miller a, miller dh. Neurology. 2009 Mar 3;72(9):806-12. doi: 10.1212/01.wnl.0000343880.13764.69. Neurology. 2009. PMID: 19255407 Free PMC article. Clinical Trial.
Diagnosis of multiple sclerosis.
Miller A. Miller A. Semin Neurol. 1998;18(3):309-16. doi: 10.1055/s-2008-1040882. Semin Neurol. 1998. PMID: 9817535 Review.
Clinical experience with COP-1 in multiple sclerosis.
Bornstein MB, Miller A, Slagle S, Weitzman M, Crystal H, Drexler E, Keilson M, Merriam A, Wassertheil-Smoller S, Spada V, et al. Bornstein MB, et al. Among authors: miller a. Neurology. 1988 Jul;38(7 Suppl 2):66-9. Neurology. 1988. PMID: 3290717 Clinical Trial.
Clinical trial design in multiple sclerosis therapy.
Weiss W, Bornstein MB, Miller A, Slagle S. Weiss W, et al. Among authors: miller a. Neurology. 1988 Jul;38(7 Suppl 2):80-1. Neurology. 1988. PMID: 3386846 No abstract available.
11,558 results
You have reached the last available page of results. Please see the User Guide for more information.